Cross-Regional Pitch & Match session

12 Jun 2025 | Park Inn by Radisson Leuven -

Benjamin DAMIEN

CEO

SAGITTA BIOTECH

Liège, Liège, Belgium

14 profile visitsSpeakerFlanders Vaccine/BioWin member

Ben is active in Tech SMEs for 22 years (as CEO, Head of BD, COO, etc). Ben has a PhD in Immunology, and a MBA from Solvay Business School.

My organisation

SAGITTA BIOTECH

SAGITTA BIOTECH

Drug discovery companies

Liège, Belgium

Sagitta Biotech is developing innovative therapies against infectious diseases and cancer based on its viral vector/mRNA platform. The technology allows us to develop very quickly vaccines that are safe and effective, but also to manufacture them at a very low cost (cents per dose) thanks to a "constant manufacturing process" (identical for all vaccines). This allows us to get significant shortcuts during development, and reduce the cost of operations for our customers.
Read more

About me

Phd in Immunology and MBA from Solvay.
Managing Biotech companies since 2003.

Social media

Skills

  • vaccines
  • Immunology
  • oncology
  • Molecular Biology
  • Management
  • corporate funding

Interests

  • Funding
  • deal making
  • startups

Speaker sessions (1)

Thursday, 12 June 2025

14:30 - 15:15

Pitch session

Location:Erasmus 1

Speaker presentation

Download speaker presentation